These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2167869)

  • 1. Liver tumor promoters stimulate growth of transplanted hepatocellular carcinomas.
    Seglen PO; Saeter G; Schwarze PE
    Hepatology; 1990 Aug; 12(2):295-300. PubMed ID: 2167869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 4-acetylaminofluorene and other tumour promoters on hepatocellular growth and binucleation.
    Gerlyng P; Grotmol T; Seglen PO
    Carcinogenesis; 1994 Feb; 15(2):371-9. PubMed ID: 7508825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of phenobarbital on the gamma-glutamyltranspeptidase activity and the remodeling of nodules induced by the initiation-selection model.
    Herren-Freund SL; Pereira MA
    Cancer Lett; 1985 Jun; 27(2):153-61. PubMed ID: 2860967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diploid growth pattern of hepatocellular tumours induced by various carcinogenic treatments.
    Schwarze PE; Saeter G; Armstrong D; Cameron RG; Laconi E; Sarma DS; Préat V; Seglen PO
    Carcinogenesis; 1991 Feb; 12(2):325-7. PubMed ID: 1847321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diploid nature of hepatocellular tumours developing from transplanted preneoplastic liver cells.
    Saeter G; Schwarze PE; Nesland JM; Seglen PO
    Br J Cancer; 1989 Feb; 59(2):198-205. PubMed ID: 2930686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fumonisin B1-induced hepatocellular and cholangiocellular tumors in male Fischer 344 rats: potentiating effects of 2-acetylaminofluorene on oval cell proliferation and neoplastic development in a discontinued feeding study.
    Lemmer ER; Vessey CJ; Gelderblom WC; Shephard EG; Van Schalkwyk DJ; Van Wijk RA; Marasas WF; Kirsch RE; Hall Pde L
    Carcinogenesis; 2004 Jul; 25(7):1257-64. PubMed ID: 14988222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth-related alterations during liver carcinogenesis: effect of promoters.
    Seglen PO; Gerlyng P
    Environ Health Perspect; 1990 Aug; 88():197-205. PubMed ID: 2272315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulatory interaction between initial clofibrate treatment and subsequent administration of 2-acetylaminofluorene or sodium phenobarbital on glutathione S-transferase positive lesion development.
    Mutai M; Tatematsu M; Aoki T; Wada S; Ito N
    Cancer Lett; 1990 Feb; 49(2):127-32. PubMed ID: 2306705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth of carcinogen-altered rat hepatocytes in the liver of syngeneic recipients promoted with phenobarbital.
    Hanigan MH; Pitot HC
    Cancer Res; 1985 Dec; 45(12 Pt 1):6063-70. PubMed ID: 3904978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of preneoplastic rat hepatocytes by intraportal injection.
    Saeter G; Schwarze PE; Nesland JM; Seglen PO
    Toxicol Pathol; 1987; 15(1):78-81. PubMed ID: 3554470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced survival and absence of progressive growth of transplanted rat liver altered eosinophilic foci and neoplastic nodules in phenobarbital-treated rats.
    Mori H; Furuya K; Williams GM
    J Natl Cancer Inst; 1983 Oct; 71(4):849-54. PubMed ID: 6194334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced drug resistance inhibits selection of initiated cells and cancer development.
    Rissler P; Torndal UB; Eriksson LC
    Carcinogenesis; 1997 Apr; 18(4):649-55. PubMed ID: 9111195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical effects of phenobarbital on mouse hepatocarcinogenesis.
    Lee GH
    Toxicol Pathol; 2000; 28(2):215-25. PubMed ID: 10805139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the tumor promoter 2-acetylaminofluorene and of 4-acetylaminofluorene on rat liver growth.
    Gerlyng P; Seglen PO
    Bull Cancer; 1990; 77(5):461-6. PubMed ID: 2400817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy and autophagic protein degradation as determinants of hepatocellular growth and survival.
    Seglen PO
    Cell Biol Toxicol; 1997 Jul; 13(4-5):301-15. PubMed ID: 9298250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of spontaneous hepatocarcinogenesis in C3H/HeN mice by transplanted hepatocellular carcinomas.
    Becker FF
    Cancer Res; 1981 Sep; 41(9 Pt 1):3320-3. PubMed ID: 6266653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of liver colony formation and hepatocellular carcinoma incidence in rats receiving intravenous injections of isogeneic liver cells isolated during hepatocarcinogenesis.
    Laishes BA; Rolfe PB
    Cancer Res; 1980 Nov; 40(11):4133-43. PubMed ID: 6110475
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of hepatocellular carcinoma in rat liver by initial treatment with benzo(a)pyrene after partial hepatectomy and promotion by phenobarbital.
    Kitagawa T; Hirakawa T; Ishikawa T; Nemoto N; Takayama S
    Toxicol Lett; 1980 Aug; 6(3):167-71. PubMed ID: 7404596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma cell lines from diethylnitrosamine phenobarbital-treated rats. Characterization and sensitivity to endothall, a protein serine/threonine phosphatase-2A inhibitor.
    Thièry JP; Blazsek I; Legras S; Marion S; Reynes M; Anjo A; Adam R; Misset JL
    Hepatology; 1999 May; 29(5):1406-17. PubMed ID: 10216123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenobarbital as a promoter in the initiation/selection process of experimental rat hepatocarcinogenesis.
    Lans M; de Gerlache J; Taper HS; Préat V; Roberfroid MB
    Carcinogenesis; 1983; 4(2):141-4. PubMed ID: 6825204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.